Geode Capital Management
AHPI

Geode Capital Management’s Allied Healthcare Products AHPI Stock Holding History

Geode Capital Management’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,327
Closed -$20K – 4915
2022
Q4 		$20K Hold
22,327
– – ﹤0.01% 4769
2022
Q3 		$29K Hold
22,327
– – ﹤0.01% 4856
2022
Q2 		$36K Buy
22,327
+624
+3% +$1.42K ﹤0.01% 4851
2022
Q1 		$70K Hold
21,703
– – ﹤0.01% 4745
2021
Q4 		$126K Hold
21,703
– – ﹤0.01% 4651
2021
Q3 		$149K Hold
21,703
– – ﹤0.01% 4553
2021
Q2 		$89K Hold
21,703
– – ﹤0.01% 4587
2021
Q1 		$102K Hold
21,703
– – ﹤0.01% 4296
2020
Q4 		$105K Hold
21,703
– – ﹤0.01% 4049
2020
Q3 		$119K Buy
21,703
+1,352
+7% +$11.4K ﹤0.01% 3863
2020
Q2 		$239K Hold
20,351
– – ﹤0.01% 3615
2020
Q1 		$356K Buy
+20,351
New +$158K ﹤0.01% 3366

Geode Capital Management's AHPI Position: Q1 2023 in Review

Geode Capital Management sold out of Allied Healthcare Products (AHPI) in Q1 2023, closing a stake of 22,327 shares — an estimated $20K sold.

Geode Capital Management first reported a position in AHPI in Q1 2020 and held it in 12 quarters. The position peaked at $356K in Q1 2020. 1 fund tracked by Wall St. Rank holds AHPI as of Q1 2023.

  • Geode Capital Management reported no remaining Allied Healthcare Products position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 22,327 Allied Healthcare Products shares in Q1 2023, an estimated $20K.
  • Geode Capital Management first reported a position in Allied Healthcare Products in Q1 2020 and held it in 12 quarters.
  • Geode Capital Management's Allied Healthcare Products position peaked at $356K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Allied Healthcare Products as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.